Mohammad Krayem
Impact in
Papers in
-
- Melanoma and MAPK Pathways 12
- PI3K/AKT/mTOR signaling in cancer 3
- Oncology 14
- Cancer-related Molecular Pathways 6
- Cutaneous Melanoma Detection and Management 4
- Co-authors
- Ahmad Awada (16 shared papers)Fabrice Journé (18 shared papers)Ahmad Najem (17 shared papers)Ghanem Ghanem (9 shared papers)Ghanem E. Ghanem (11 shared papers)Dominique Bron (4 shared papers)Nathalie Meuleman (3 shared papers)Mehdi Najar (3 shared papers)
In The Last Decade
Mohammad Krayem
27 papers receiving 708 citations
Peers
Comparison fields: 5 of 90
- Genetics 128
- Oncology 290
- Cancer Research 111
- Immunology 145
- Molecular Biology 414
Countries citing papers authored by Mohammad Krayem
This map shows the geographic impact of Mohammad Krayem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Krayem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Krayem more than expected).
Fields of papers citing papers by Mohammad Krayem
This network shows the impact of papers produced by Mohammad Krayem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Krayem. The network helps show where Mohammad Krayem may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Krayem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 91 | |
| 2 | 2017 | 83 | |
| 3 | 2021 | 70 | |
| 4 | 2018 | 69 | |
| 5 | 2016 | 45 | |
| 6 | 2022 | 41 | |
| 7 | 2017 | 41 | |
| 8 | 2018 | 31 | |
| 9 | 2021 | 31 | |
| 10 | 2017 | 28 | |
| 11 | 2014 | 21 | |
| 12 | 2016 | 21 | |
| 13 | 2019 | 20 | |
| 14 | 2022 | 20 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 15 | |
| 17 | 2023 | 12 | |
| 18 | 2019 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2022 | 10 |
About Mohammad Krayem
Mohammad Krayem is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Cancer Research, having authored 27 papers that have together received 716 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (12 papers), Cancer-related Molecular Pathways (6 papers), Cutaneous Melanoma Detection and Management (4 papers), Mesenchymal stem cell research (3 papers), Cancer Research and Treatments (3 papers), Immunotherapy and Immune Responses (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Genetics (128 citations), Oncology (290 citations), Cancer Research (111 citations), Immunology (145 citations) and Molecular Biology (414 citations). Mohammad Krayem has collaborated with scholars based in Belgium, France and Canada. Frequent co-authors include Ahmad Awada, Fabrice Journé, Ahmad Najem, Ghanem Ghanem, Ghanem E. Ghanem, Dominique Bron, Nathalie Meuleman, Mehdi Najar, Laurence Lagneaux and Sven Saussez. Their work appears in journals such as Cancers, European Journal of Cancer, Frontiers in Oncology, Cells and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.